Immunogenicity and Safety of Dengue Tetravalent Vaccine (TDV) and Recombinant 9-valent Human Papillomavirus Vaccine (9vHPV) in Participants Aged ≥9 to <15 Years
Clinical trial NCT04313244 · COMPLETED
Trial details
- NCT number
- NCT04313244
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-15
- Primary completion
- 2022-02-21
- Enrollment
- 614
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.